Corporate leaders are increasingly prioritizing results over employee comfort, with CEOs like Unilever's Fernando Fernandez demanding "volu...

Medics are working to evacuate two individuals with hantavirus symptoms from a luxury cruise ship off West Africa after an outbreak claimed...

US company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...

Sun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...

“We introduce the product after years of research and investment, while companies like Natco merely copy and manufacture the product,” said...

Bahr advocating stronger cooperation between Indian and Germany in the health sector, especially in immigration of medical and nursing prof...

Bayer today said it will continue to defend its IP rights while expressing disappointment at the IPAB decision to reject the firm's plea to...

In March, India allowed Natco Pharma to legally make and sell a low-cost version of cancer drug Nexavar at 3% of the original medicine's pr...

Bayer has filed an appeal against a patents order, which allowed domestic drug maker Natco Pharma to sell a generic version of the German f...

German drug co recalled two batches of cancer drug made by its Indian arm on cross-contamination.

Cipla has launched a copycat version of German pharma company Bayer’s cancer medicine Nexavar at one-tenth the price.

The Delhi HC dismissed an appeal by German drugmaker Bayer that sought to stop Cipla from obtaining a marketing approval from the country’s...

Indian pharmaceutical companies are reworking their strategies for Europe to cope with the intense pressure on drug prices because of chang...

The bid is scheduled to open in the first week of November. Germany, which is the world’s second largest drug market, looks for ways to cur...

Leading Indian drug makers with a large presence in Germany could face substantial pressure on margins following a recent tender by a Germa...

Dr Reddy’s Laboratories (DRL) aims to shift production of about a dozen top-selling products of its German arm Betapharm to India by July 2...

Last month, the German government announced its decision to change rules to induce drugmakers to charge less for their products.